Dupilumab‐associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report.
Autor: | Galluzzo, Marco, Tofani, Lorenzo, Spelta, Sara, Talamonti, Marina, Micera, Alessandra, Bianchi, Luca, Coassin, Marco, Bonini, Stefano, Di Zazzo, Antonio |
---|---|
Zdroj: | Skin Health & Disease; Jun2024, Vol. 4 Issue 3, p1-5, 5p |
Databáze: | Complementary Index |
Externí odkaz: |